Friday, March 25, 2022

< + > Moderna Stock Plunges Despite 'Vaccine Day' Touting 31 New Shots And $21 Billion In Sales—Here's Why

One analyst blasted Moderna's flu vaccine results as a "non-starter" clinically, while others said investors are still too focused on Covid.

No comments:

Post a Comment

< + > Stop Waiting on Mandates: CMS Challenges Health IT to Act Now

“We’re the government and we’re here to help.” That’s a common punchline, but based on recent IT announcements from CMS, this line may turn ...